Personalizing Precision Medicine highlights the triumphs and challenges of precision medicine on a global scale.
Is your portfolio fit for the future or fashioned on the past? As M&A appetite remains high, the latest EY Global Capital Confidence Barometer notes portfolio transformation is key.
The pet industry is seeing high levels of M&A activity driven by strategic consumer packaged goods buyers, retailers and investors.
M&A is increasingly important to the growth and survival of consumer products and retail companies – EY-Parthenon highlights new route to market structures to maximize the value of CPR transactions.
EY-Parthenon explores how consumer products companies can play, execute, and win when expanding internationally.
Read about how to help maximize shareholder value in the EY 2018 Global Corporate Divestment Study.
EY-Parthenon’s life science article in PM360 explores the year ahead for new potential product launches for oncology, neurology, and rare blood disorders.
The EY-Parthenon team is committed to bringing unconventional yet pragmatic thinking together with our clients’ smarts to deliver actionable strategies for real impact in today’s complex business landscape.